Apolipoprotein E polymorphism and lipoprotein compositions in patients with Behçet's disease

International Journal of Dermatology

Volumn 43, Issue 12, 2004, Pages 900-903

  Tursen, Umit ^a   Eskandari, Gulcin ^a   Kaya, Tamer Irfan ^a   Tamer, Lulufer ^a   Ikizoglu, Guliz ^a   Atik, Ugur ^a  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; BEHCET DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPID COMPOSITION; MALE; STATISTICAL DISTRIBUTION; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALLELES; APOLIPOPROTEINS E; BEHCET SYNDROME; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LIPOPROTEINS; MALE; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 10444235112     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02020.x     Document Type: Article

References (33)

1. Behçet H. Uber rezidivierende aphthouse dutch ein virus verursachte Geschwuere am Mund, am Auge und an den Genitalien. Dermatol Monatsschr Wochenschr 1937; 105: 1152-1157.
2. Alpsoy E, Aktekin MErH, Cayirli C, et al. Distribution and frequency of papulopustular lesions in Behcet's disease: a randomized, controlled study. Int J Dermatol 1998; 37: 839-842.
3. Gurler A, Boyvat A, Tursen U. Clinical manifestations of Behcet's disease; an analysis of 2147 patients. Yonsei Med J 1997; 38: 423-427.
4. Onder M, Gurer MA. The multiple faces of Behcet's disease and its etiological factors. J Eur Acad Dermatol Venereol 2001; 15 126-136.
5. Alpsoy E, Yilmaz E, Savas A, et al. HLA antigens and linkage disequilibrium patterns in Turkish Behcet's patients. J Dermatol 1998; 25: 158-162.
6. O'Duffy JD. Vasculitis in Behcet's disease. Rheum Dis Clin North Am 1990; 16: 423-431.
7. Pronai L, Ichikawa Y, Nakazawa H, et al. Enhanced superoxide generation and the decreased superoxide generation scavenging activity of peripheral blood leukocytes in Behcet's disease - effects of colchicine. Clin Exp Rheum 1991; 9: 227-233.
8. Deger O, Orem A, Akyol N, et al. PMN elastase levels in patients with Behcet's disease. Clin Chim Acta 1995; 236: 129-134.
9. Niwa Y, Miyake S, Sakane T, et al. Auto-oxidative damage in Behcet's disease - endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1981; 49: 247-255.
10. Mitamura T, Ohno S, Ariga H, et al. Lipoprotein cholesterol concentrations in patients with Behcet's disease. Clin Chim Acta 1988; 175: 277-284.
11. Orem A, Deger O, Memis O, et al. Lp (a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behcet's disease. Ann Rheum Dis 1995; 54: 726-729.
12. Orem A, Efe H, Deger O, et al. Relationship between lipid peroxidation and disease activity in patients with Behcet's disease. J Dermatol Sci 1997; 16: 11-16.
13. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-630.
14. Frikke-Schmidt R. Context-dependent and invariant associations between ApoE genotype and levels of lipoproteins and risk of ischemic heart disease: a review. Scand J Clin Lab Invest 2000; 60: 3-26.
15. Chang YT, Tsai SF, Wang WJ, et al. A study of apolipoproteins E and A-I in cutaneous amyloidosis. Br J Dermatol 2001; 145: 422-427.
16. Furumoto H, Nakamura K, Hamamato Y, et al. Association of apolipoprotein allele E2 with psoriasis vulgaris. Arch Dermatol Res 1997; 289: 497-500.
17. Netea MG, Demacker PN, De-Bont N, et al. Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice. Infect Immunol 1997; 65: 2663-2667.
18. Shimokawa O, Nakayama H. Inactivation of penicillin-induced staphylococcal L-forms by human serum high density lipoprotein. FEMS Microbiol Lett 1997; 156: 113-117.
19. Bont N, Netea MG, Demacker PNM, et al. Apolipoprotein E-deficient mice have response to Klebsiella pneumonia. Eur J Clin Invest 2000; 30: 818-822.
20. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335: 1078-1080.
21. Mizushima Y. Skin hypersensitivity to streptococcal antigens in Behcet's disease: a multicenter study. J Rheumatol 1989; 16 506-511.
22. Kaneko F, Takahashi Y, Muramatsu Y, et al. Immunological studies on aphthous ulcer and erythema nodosum-like eruptions in Behcet's disease. Br J Dermatol 1985; 113: 303-312.
23. Calguneri M, Ertenli I, Kiraz S, et al. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet's disease. Dermatology 1996; 192: 125-128.
24. Orem A, Cimsit G, Deger O, et al. Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behcet's disease. Dermatology 1999; 198: 243-246.
25. Van-Leten BJ, Fogelman AM, Haberland ME, et al. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1986; 83 2704-2708.
26. Harris HW, Grunfeld C, Feingold KR, et al. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993; 91: 1028-1034.
27. Flegel WA, Wolpl A, Mannel DN, et al. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect Immunol 1989; 57: 2237-2245.
28. Netea MG, Demacker PN, Kullberg BJ, et al. Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections. J Clin Invest 1996; 97: 1366-1372.
29. Levine DM, Parker TS, Donnelly TM, et al. In vivo protection against endotoxin by plasma high-density lipoprotein. Proc Natl Acad Sci USA 1993; 90: 12,040-12,044.
30. Miller GJ. Epidemiologic and clinical aspects of high-density lipoproteins. In: Miller NE, Miller GJ, eds. Clinical and Metabolic Aspects of High-Density Lipoproteins. Amsterdam: Elsevier, 1984: 47-74.
31. Lessof MH, Jefferys DB, Lehner T, et al. Corticosteroids and azathioprine; their use in Behcet's syndrome. In: Lehner T, Barnes CG, eds. Behcet's Syndrome; Clinical and Immunological Features. London: Academic Press, 1979: 267-275.
32. Ozkan M, Emel O, Ozdemir M, et al. M-mode, 2-D and Doppler echocardiography study in 65 patients with Behcet's disease. Eur Heart J 1992; 13: 638-641.
33. De Bont N, Netea MG, Demacker PN, et al. Apolipoprotein E knock-out mice are highly susceptible to endotoxinemia and Klebsiella pneumonia infection. J Lipid Res 1999; 40: 680-685.